Results 31 to 40 of about 40,585 (248)

Cost–effectiveness of overactive bladder treatments from a US commercial and payer perspective

Journal of Comparative Effectiveness Research, 2023
Aim: The cost–effectiveness of treatment options (anticholinergics, β3-adrenoceptor agonists, onabotulinumtoxinA, sacral nerve stimulation and percutaneous tibial stimulation [the latter two including new rechargeable neurostimulators]) for the ...
Brian Murray, Jennifer Miles-Thomas, Amy J Park, Victor B Nguyen, Amy Tung, Patrick Gillard, Anjana Lalla, Victor W Nitti, Christopher J Chermansky   +8 more
doaj   +1 more source

Anti-cholinergic drug burden in patients with dementia increases after hospital admission: a multicentre cross-sectional study

BMC Geriatrics, 2022
Background Anticholinergic medications are drugs that block cholinergic transmission, either as their primary therapeutic action or as a secondary effect.
Annabelle Hook, Jessica L. Randall, Carla M. Grubb, Natalie Ellis, Jack Wellington, Aayushi Hemmad, Agisilaos Zerdelis, Andrew R. D. Winnett, Benjamin D. W. Geers, Bethany Sykes, Charlotte N. Auty, Cecilia Vinchenzo, Christiane E. Thorburn, Daniella Asogbon, Emily Granger, Heather Boagey, Juliet Raphael, Kajal Patel, Kartik Bhargava, Mary-Kate M. Dolley, Matthew J. Maden, Mehdin M. Shah, Qao M. Lee, Ratnaraj Vaidya, Simran Sehdev, Sneha Barai, Sophie Roche, Uzair Khalid, David A. Codling, Judith R. Harrison   +29 more
doaj   +1 more source

Anticholinergic therapy for bronchiectasis

, 2001
Background Anticholinergic agents block bronchoconstriction mediated by the vagus nerve and may also dry up bronchial secretions. They are effective in obstructive airways disease and may be beneficial in bronchiectasis Objectives To determine the effect
Holt, Kay, Lasserson, Toby J., Evans, David J., Milan, Stephen, Greenstone, Michael   +4 more
core   +4 more sources

CONSERVATIVE TREATMENT OF LOWER URINARY TRACT DYSFUNCTION

Slovenska pediatrija, 2023
Lower urinary tract dysfunction, closely related to bowel dysfunction, means functional abnormalities of the bladder and urethra. Different types of lower urinary tract dysfunction are divided according to symptoms or according to the cause. Treatment is
Anamarija Meglič, Matjaž Kopač
doaj   +1 more source

Effects of (a Combination of) the Beta₂-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction

Cells, 2021
Expression of bronchodilatory β2-adrenoceptors and bronchoconstrictive muscarinic M3-receptors alter with airway size. In COPD, (a combination of) β2-agonists and muscarinic M3-antagonists (anticholinergics) are used as bronchodilators.
Harm Maarsingh, Anouk Oldenburger, Bing Han, Annet B. Zuidhof, Carolina R. S. Elzinga, Wim Timens, Herman Meurs, Ramadan B. Sopi, Martina Schmidt   +8 more
doaj   +1 more source

Comentarios sobre la herramienta web Anticholinergic Burden Calculator. RÉPLICA

, 2019
Comment about Anticholinergic Drug Scale (ADS)
Villalba Moreno, Ángela, Santos-Ramos, Bernardo, Sánchez Fidalgo, Susana, Alfaro Lara, Eva Rocío   +3 more
core   +1 more source

Pharmacogenetic associations of CYP2D6 and CYP2C19 variants with anticholinergic drug burden and hyposalivation

Frontiers in Pharmacology
IntroductionAnticholinergic medications frequently cause hyposalivation (decreased saliva flow) through parasympathetic inhibition. This adverse effect is related to anticholinergic burden, reflecting the cumulative exposure to drugs with anticholinergic
Olga A. Korczeniewska, Scott Diehl, Abdul Basir Barmak, Tong Tong Wu, Eli Eliav, Szilvia Arany   +5 more
doaj   +1 more source

Histamine and the mechanisms of nausea and vomiting: Translating the uncertain pharmacology of cyclizine

British Journal of Clinical Pharmacology, EarlyView.
Abstract Cyclizine is a long‐established, short‐acting drug, registered for preventing motion sickness, post‐operative nausea and vomiting (PONV) and ‘vomiting of known cause’. The latter is not defined but may include pregnancy and patients receiving palliative care, historically accepted without large, controlled trials.
Gareth J. Sanger, Paul L. R. Andrews
wiley   +1 more source

Feasibility of Self-administered Neuromodulation for Neurogenic Bladder in Spinal Cord Injury [PDF]

International Neurourology Journal, 2019
Purpose To determine if self-administered transcutaneous tibial nerve stimulation (TTNS) is a feasible treatment option for neurogenic bladder among people with spinal cord injury (SCI) who utilize intermittent catheterization for bladder management ...
Argyrios Stampas, Rose Khavari, Joel E. Frontera, Suzanne L. Groah   +3 more
doaj   +1 more source

Opsoclonus in Pediatric Patients: Differential Diagnosis and a Practical Approach to Evaluation

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Opsoclonus is an ocular dyskinesia characterized by involuntary, arrhythmic, multidirectional saccades. In pediatrics, opsoclonus is most commonly attributed to the rare neuroinflammatory disorder opsoclonus‐myoclonus‐ataxia syndrome (OMAS), typically considered a paraneoplastic syndrome associated with neural crest tumors. However, opsoclonus
Aubrey C. Reed, Supreet S. Randhawa, Jason H. Peragallo, Prabhumallikarjun Patil, Grace Gombolay, Varun Kannan   +5 more
wiley   +1 more source